BROADCASTS.com

I am thrilled to present the last class of our Lipid Masterclass series today with the esteemed Dr. Thomas Dayspring. Dr. Dayspring is board-certified in internal medicine and clinical lipidology and is a fellow of the American College of Physicians and the National Lipid Association.\xa0\nToday, we round things out by diving into medications for lipid abnormalities and discussing lipid physiology, with Dr. Dayspring shedding light on insulin resistance and statins and cautioning against statin use for those predisposed to diabetes or insulin resistance. He also explains why LDL particle size is not worth testing and discusses ways to identify specific laboratory abnormalities.\xa0\nBe sure to stay tuned for the AMA session to follow, where Dr. Dayspring will answer listeners\u2019 questions.\xa0\nIt has been a privilege engaging with Dr. Dayspring throughout this masterclass series. I know you will have learned a lot from it!\n\nIN THIS EPISODE YOU WILL LEARN:\n\xb7 The lack of research and consistency in addressing the needs of women in various stages of life\n\xb7 Dr. Dayspring discusses the use of bile acid sequestrants for lowering LDL cholesterol\n\xb7 Dr. Dayspring discusses the history of bile acid sequestrant use, explaining why their use is limited\n\xb7 How bempedoic acid and statins lower LDL cholesterol\n\xb7 Potential contraindications for bempedoic acid\n\xb7 The benefits and risks of using fibrates to reduce heart attacks\n\xb7 Dr. Dayspring explains why fibrates work best for genetic hypertriglyceridemia\n\xb7 Why reducing ApoB is essential for atherosclerosis patients, especially for high-risk patients\n\xb7 Dr. Dayspring explains why small LDL particles are dangerous\n\xb7 The ideal ApoB level for those who have no heart disease and are not diabetic\xa0\n\nBio:\nThomas Dayspring MD is a Fellow of both the American College of Physicians and the National Lipid Association and is certified in internal medicine and clinical lipidology. After practicing in New Jersey for 37 years, in 2012, he moved to Virginia to serve as an educational director for a nonprofit cardiovascular foundation until mid-2019 as a Chief Academic Advisor for two major CV laboratories. Since then, he has served as a virtual cardiovascular/lipidology educator. Career-wise, he has given over 4000 domestic (in all 50 states) and several international lectures, including over 600 CME programs on atherothrombosis, lipids/lipoproteins (and their treatment), vascular biology, biomarker testing, and women\u2019s cardiovascular issues. He has authored several manuscripts and lipid textbook chapters and performed several podcasts. For several years, he was an Associate Editor of the Journal of Clinical Lipidology. He received the 2011 National Lipid Association\u2019s Presidents Award for services to clinical lipidology and the 2023 Foundation of NLA Clinician/Educator Award. He has over 34K followers on his educational Twitter (X) feed (@Drlipid). He has Gold Heart Member status as a professional member of the American Heart Association, and he serves as a Social Media Ambassador for the European Atherosclerosis Society and the National Lipid Association.\n\nConnect with Cynthia Thurlow\n\nFollow on Twitter\n\n\nInstagram\n\nLinkedIn\n\nCheck out Cynthia\u2019s website\n\n\nSubmit your questions to support@cynthiathurlow.com\n\n\n\nConnect with Dr. Thomas Dayspring\n\nOn Twitter (@DrLipid)\n\nOn LinkedIn